EXEL Exelixis Forecast, Technical & Fundamental Analysis

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Get AI intraday signals

EXEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EXEL
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

EXEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EXEL
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

EXEL is expected to report earnings to fall 59.50% to 34 cents per share on October 30

Q3'24

Est.

$0.34

Q2'24

Beat

by $0.53

Q1'24

Missed

by $0.06

Q4'23

Beat

by $0.10

Q3'23

Missed

by $0.05

The last earnings report on August 06 showed earnings per share of 83 cents, beating the estimate of 31 cents. With 979.67K shares outstanding, the current market capitalization sits at 7.41B.

A.I. Advisor

published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1851 Harbor Bay Parkway

Phone

+1 650 837-7000

Employees

1310

Web

https://www.exelixis.com

Interesting Tickers

ETFs / NAME	Price $	Chg $	Chg %
		1 Day
SPDV	33.77	0.37	+1.10%
AAM S&P 500 High Dividend Value ETF
VIGI	87.14	0.39	+0.45%
Vanguard Intl Div Apprec ETF
KXI	64.49	0.23	+0.36%
iShares Global Consumer Staples ETF
ESMV	28.61	0.10	+0.36%
iShares ESG MSCI USA Min Vol Factor ETF
FEMB	28.41	-0.12	-0.42%
First Trust Emerging Mkts Lcl Ccy Bd ETF

EXEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with SRPT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then SRPT could also see price increases.

Ticker / NAME	Correlation To EXEL	1D Price Change %
EXEL	100%	+1.56%
SRPT - EXEL	36% Loosely correlated	+1.38%
ALNY - EXEL	34% Loosely correlated	-0.57%
TECH - EXEL	33% Poorly correlated	+1.05%
MRSN - EXEL	32% Poorly correlated	+4.95%
ORMP - EXEL	32% Poorly correlated	-2.49%
More